AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (May 5, 2009). doi:10.1152/ajpendo.90673.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/E50    most recent
90673.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haywood, S. C
Right arrow Articles by Fisher, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haywood, S. C
Right arrow Articles by Fisher, S.
Submitted on August 6, 2008
Revised on April 30, 2009
Accepted on May 1, 2009

Central, but not Systemic Lipid Infusion, Augments the Counterregulatory Response to Hypoglycemia

Samuel C Haywood1, Adam J Bree1, Erwin Puente1, Dorit Daphna-Iken1, and Simon Fisher1*

1 Washington University

* To whom correspondence should be addressed. E-mail: sfisher{at}im.wustl.edu.

This study tests the hypothesis that lipids could act as an alternative fuel source in the brain during insulin induced hypoglycemia. Male Sprague-Dawley rats were subjected to hyperinsulinemic (5 mU.kg-1.min-1) hypoglycemic (~50mg/dl) clamps. In protocol 1, Intralipid (IL), a fat emulsion, was infused intravenously in order to prevent the fall in free fatty acid levels that occurs in response to hyperinsulinemic hypoglycemia. Intravenous lipid infusion did not alter the counterregulatory responses to hypoglycemia. To test whether Intralipid could have central effects in mediating the counterregulatory response to hypoglycemia; in protocol 2, the brains of pre-cannulated rats were intracerebroventricularly (ICV) infused with Intralipid, or artificial cerebrospinal fluid (aCSF) as control. Unexpectedly, the epinephrine and glucagon response to hypoglycemia was significantly augmented with ICV IL infusion. To determine if central IL infusion could restore defective counterregulation; in protocol 3, rats were made recurrently hypoglycemic (RH) for three days and on the fourth day underwent hyperinsulinemic hypoglycemic clamps with ICV IL or aCSF infusion. RH rats had the expected impaired epinephrine response to hypoglycemia and ICV IL infusion again significantly augmented the epinephrine response in RH rats to normal. With regard to our experimental model of hypoglycemic counterregulation, we conclude that, 1) systemic lipid infusion did not alter the counterregulatory response to hypoglycemia, 2) the intracerebroventricular infusion of lipids markedly increased CSF FFA levels and paradoxically augmented the epinephrine and glucagon responses, and 3) the blunted sympathoadrenal response in recurrently hypoglycemic rats was completely normalized with the ICV lipid infusion. It is concluded that in the setting of insulin-induced hypoglycemia, increased brain lipids can enhance the sympathoadrenal response.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.